Paprottka PM - Search Results

1

Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT.

Hartenbach M, Weber S, Albert NL, Hartenbach S, Hirtl A, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR. Hartenbach M, et al. Among authors: paprottka pm. J Nucl Med. 2015 Nov;56(11):1661-6. doi: 10.2967/jnumed.115.158758. Epub 2015 Sep 24. J Nucl Med. 2015. PMID: 26405170 Free article.

2

Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.

Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Todica A, Bartenstein P, Hacker M, Haug AR. Ilhan H, et al. J Nucl Med. 2015 Nov;56(11):1654-60. doi: 10.2967/jnumed.115.162685. Epub 2015 Aug 27. J Nucl Med. 2015. PMID: 26315830 Free article.

3

Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.

Fendler WP, Philippe Tiega DB, Ilhan H, Paprottka PM, Heinemann V, Jakobs TF, Bartenstein P, Hacker M, Haug AR. Fendler WP, et al. Among authors: paprottka pm. J Nucl Med. 2013 Aug;54(8):1202-8. doi: 10.2967/jnumed.112.116426. Epub 2013 May 31. J Nucl Med. 2013. PMID: 23729697 Free article.

4

Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer.

Michl M, Lehner S, Paprottka PM, Ilhan H, Bartenstein P, Heinemann V, Boeck S, Albert NL, Fendler WP. Michl M, et al. Among authors: paprottka pm. J Nucl Med. 2016 Mar;57(3):355-60. doi: 10.2967/jnumed.115.165613. Epub 2015 Nov 25. J Nucl Med. 2016. PMID: 26609176 Free article.

5

Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.

Fendler WP, Lechner H, Todica A, Paprottka KJ, Paprottka PM, Jakobs TF, Michl M, Bartenstein P, Lehner S, Haug AR. Fendler WP, et al. Among authors: paprottka pm, paprottka kj. J Nucl Med. 2016 Apr;57(4):517-23. doi: 10.2967/jnumed.115.165050. Epub 2016 Jan 7. J Nucl Med. 2016. PMID: 26742710 Free article.

6

Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma.

Hartenbach M, Weber S, Pilz M, Hartenbach S, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR, Albert NL. Hartenbach M, et al. Among authors: paprottka pm. Clin Nucl Med. 2018 Jul;43(7):477-481. doi: 10.1097/RLU.0000000000002092. Clin Nucl Med. 2018. PMID: 29659390

7

Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer.

Fendler WP, Ilhan H, Paprottka PM, Jakobs TF, Heinemann V, Bartenstein P, Khalaf F, Ezziddin S, Hacker M, Haug AR. Fendler WP, et al. Among authors: paprottka pm. Eur Radiol. 2015 Sep;25(9):2693-700. doi: 10.1007/s00330-015-3658-7. Epub 2015 Feb 28. Eur Radiol. 2015. PMID: 25721320

8

Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.

Paprottka KJ, Schoeppe F, Ingrisch M, Rübenthaler J, Sommer NN, De Toni E, Ilhan H, Zacherl M, Todica A, Paprottka PM. Paprottka KJ, et al. Among authors: paprottka pm. Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1185-1193. doi: 10.1007/s00259-017-3646-z. Epub 2017 Feb 14. Eur J Nucl Med Mol Imaging. 2017. PMID: 28197686

9

Prediction of ⁹⁰Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests.

Ingrisch M, Schöppe F, Paprottka K, Fabritius M, Strobl FF, De Toni EN, Ilhan H, Todica A, Michl M, Paprottka PM. Ingrisch M, et al. Among authors: paprottka pm, paprottka k. J Nucl Med. 2018 May;59(5):769-773. doi: 10.2967/jnumed.117.200758. Epub 2017 Nov 16. J Nucl Med. 2018. PMID: 29146692 Free article.

10

Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.

Hoffmann RT, Paprottka PM, Schön A, Bamberg F, Haug A, Dürr EM, Rauch B, Trumm CT, Jakobs TF, Helmberger TK, Reiser MF, Kolligs FT. Hoffmann RT, et al. Among authors: paprottka pm. Cardiovasc Intervent Radiol. 2012 Feb;35(1):105-16. doi: 10.1007/s00270-011-0142-x. Epub 2011 Mar 24. Cardiovasc Intervent Radiol. 2012. PMID: 21431970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters